Scorpion to build a biomanufacturing facility in Kansas

Scorpion Biological Services will build a new 500,000-square-foot biomanufacturing facility in Kansas. Within the next seven years, the company will invest USD 650M in the project and create 500 new jobs in Manhattan, KS. The facility will support the development of vaccines that enable an accelerated response to global biological threats. In addition, Scorpion Biological Services intends to provide commercial level development, manufacturing, and bioanalytical testing services at every stage for biopharmaceutical products on a fee-for-service basis to the global health care industry.

The combination of a world-class public research university, innovative private sector partners, critical national security and the skill and strength of the Kansas workforce led Scorpion to choose Manhattan for its new facility.

The project is the result of partnerships between the Kansas Department of Commerce, Kansas State University, Kansas State University Innovation Partners, the City of Manhattan, the Manhattan Chamber of Commerce, Pottawatomie County, Pottawatomie County Economic Development Corporation, Manhattan Area Technical College, Evergy, CRB and Realty Trust Group.

Previous articleUniper & Shell to produce blue hydrogen at Killingholme
Next articleCEMEX and 3M to process their industrial waste
Heat Exchanger World is a leading international magazine covering all aspects of the product supply chain of heat exchangers. Heat Exchanger World is part of the KCI Group of Companies. We are a leading knowledge, communication and information company connecting business-to-business professionals by building and sustaining global communities, solving their information needs and helping them to develop their professional life and friendships.